CD26/dipeptidyl peptidase IV: A comparative study of healthy persons and kidney transplant recipients before and early after transplantation

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1383-1388

  Leicht, Simone ^a   Shipkova, Maria ^a   Klett, Corinne ^a   Gert, Helena ^a   Altrock, Eva ^a   Wilhelm, Jens ^a   Bolley, Renate ^a   Wollmeyer, Jochen ^a   Ender, Andrea ^a   Luz, Beate ^a   Olbricht, Christoph ^a   Wieland, Eberhard ^a  

^a KLINIKUM STUTTGART   (Germany)

Author keywords

Biomarkers; CD26; Dipeptidyl peptidase IV activity; Kidney transplantation; SCD26; T cell activation

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DIALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENDER; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY;

BIOMARKERS; CD26; DIPEPTIDYL PEPTIDASE IV ACTIVITY; KIDNEY TRANSPLANTATION; SCD26; T CELL ACTIVATION;

AGED; ANTIGENS, CD3; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIPEPTIDYL PEPTIDASE 4; ENZYME ASSAYS; FEMALE; GENE EXPRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84884354863     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.04.006     Document Type: Article

References (24)

1. Matteucci E., Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 2009, 16:2943-2951.
2. Shipkova M., Wieland E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta 2012, 413:1338-1349.
3. Hopsu-Havu V.K., Glenner G.G. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 1966, 7:197-201.
4. Nagatsu, Nagatsu T., Yamamot Hydrolysis of amino acid beta-naphthylamides by aminopeptidases in human parotid salva and human serum. Experientia 1968, 24:347-348.
5. Fox D.A., Hussey R.E., Fitzgerald K.A., Acuto O., Poole C., Palley L., et al. Ta1, a novel 105kD human T cell activation antigen defined by a monoclonal antibody. J Immunol 1984, 133:1250-1256.
6. Cordero O.J., Salgado F.J., Nogueira M. On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother 2009, 58:1723-1747.
7. Ohnuma K., Hosono O., Dang N.H., Morimoto C. Dipeptidyl peptidase in autoimmune pathophysiology. Adv Clin Chem 2011, 53:51-84.
8. Fan H., Yan S., Stehling S., Marguet D., Schuppaw D., Reutter W. Dipeptidyl peptidase IV/CD26 in T cell activation, cytokine secretion and immunoglobulin production. Adv Exp Med Biol 2003, 524:165-174.
9. Kubota T., Flentke G.R., Bachovchin W.W., Stollar B.D. Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol 1992, 89:192-197.
10. Ansorge S., Nordhoff K., Bank U., Heimburg A., Julius H., Breyer D., et al. Novel aspects of cellular action of dipeptidyl peptidase IV/CD26. Biol Chem 2011, 392:153-168.
11. Korom S., De Meester I., Maas E., Stein A., Wilker S., Jung F., et al. CD26 expression and enzymatic activity in recipients of kidney allografts. Transplant Proc 2002, 34:1753-1754.
12. Korom S., De Meester I., Stadlbauer T.H., Chandraker A., Schaub M., Sayegh M.H., et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 1997, 63:1495-1500.
13. Zhai W., Cardell M., De Meester I., Augustyns K., Hillinger S., Inci I., et al. Intragraft DPPIVDPPIV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. J Heart Lung Transplant 2007, 26:174-180.
14. Wieland E., Shipkova M., Martius Y., Hasche G., Klett C., Bolley R., et al. Association between pharmacodynamic biomarkers and clinical events in the early phase after kidney transplantation: a single-center pilot study. Ther Drug Monit 2011, 33:341-349.
15. Shipkova M., Krizan E., Klett C., Leicht S., Wieland E. Effect of immunosuppressants on CD26/dipetidyl peptidase IV expression on CD3 cells in vitro. Ther Drug Monit 2009, 31:660.
16. Wieland E., Olbricht C.J., Süsal C., Gurragchaa P., Böhler T., Israeli M., et al. Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit 2010, 32:560-572.
17. Hildebrandt M., Rose M., Mayr C., Schüler C., Reutter W., Salama A., et al. Alterations in expression and in serum activity of dipeptidy peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scand J Immunol 1999, 50:536-540.
18. Galli F. Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant 2007, 22:20-36.
19. Xu P., Derynck R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell 2010, 37:551-566.
20. Levine S.J., Logun C., Chopra D.P., Rhim J.S., Shelhamer J.H. Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55kDa TNF receptor from human airway epithelial cells. Am J Respir Cell Mol Biol 1996, 14:254-261.
21. Matsuda S., Koyasu S. Regulation of MAPK signaling pathways through immunophilin-ligand complex. Curr Top Med Chem 2003, 3:1358-1367.
22. Kimball P.M., Kerman R.K., Van Buren C.T., Lewis R.M., Katz S., Kahan B.D. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication. Transplantation 1993, 55:1128-1132.
23. Wang C.H., Cherng W.J., Yang N.I., Hsu C.M., Yeh C.H., Lan Y.I., et al. Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Am J Physiol Regul Integr Comp Physiol 2008, 294:811-818.
24. Kobayashi H., Hosono O., Mimori T., Kawasaki H., Dang N.H., Tanaka H., et al. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. J Rheumatol 2002, 29:1858-1866.